Despite Lower Sales, Solvay's Margin Gains Might Change The Case For Investing In Solvay (ENXTBR:SOLB)
Reviewed by Sasha Jovanovic
- Solvay SA recently reported its third quarter and nine-month 2025 results, revealing sales of €1,011 million and nine-month sales of €3.16 billion, both lower than the prior year, but with third quarter net income rising to €34 million from €19 million a year ago.
- An interesting aspect is that despite lower sales and revenue figures, Solvay managed to increase earnings per share and net income in the third quarter compared to the same period last year, signaling potential cost controls or margin improvement.
- We'll explore what Solvay's improved quarterly net income means for its medium-term margin growth and overall investment outlook.
These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
Solvay Investment Narrative Recap
To be a shareholder in Solvay, you need to believe in its ability to move beyond cyclical pricing pressures in chemicals by capitalizing on growth opportunities in rare earths, digitalization, and sustainability. The latest quarterly results, showing improved net income despite revenue decline, suggest cost controls but do not materially shift the short-term catalyst: a sustained turnaround in demand and pricing for key segments. However, risks from overcapacity and flat demand remain prominent in the near term.
Among recent announcements, Solvay’s expanded partnership for recycled rare earth oxide supply stands out as most closely linked to its growth narrative. While the short-term margin improvement owes much to efficiency, medium-term expectations still rest on the successful execution of new materials and rare earths plans, which may help offset some cyclical headwinds if demand stabilizes.
But in contrast, investors should also consider how ongoing pricing pressure and global overcapacity in soda ash could ...
Read the full narrative on Solvay (it's free!)
Solvay's outlook anticipates €4.6 billion in revenue and €308.9 million in earnings by 2028. This reflects a -2.7% annual revenue decline and a €169.9 million increase in earnings from the current level of €139.0 million.
Uncover how Solvay's forecasts yield a €28.70 fair value, a 12% upside to its current price.
Exploring Other Perspectives
Simply Wall St Community members estimated Solvay’s fair value between €17.21 and €44.11, with four perspectives captured. While some expect future earnings growth to accelerate, the risk of persistent weak demand remains a concern for the company’s outlook.
Explore 4 other fair value estimates on Solvay - why the stock might be worth as much as 72% more than the current price!
Build Your Own Solvay Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Solvay research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
- Our free Solvay research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Solvay's overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
Our top stock finds are flying under the radar-for now. Get in early:
- Uncover the next big thing with financially sound penny stocks that balance risk and reward.
- The latest GPUs need a type of rare earth metal called Neodymium and there are only 36 companies in the world exploring or producing it. Find the list for free.
- Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ENXTBR:SOLB
Reasonable growth potential with proven track record.
Similar Companies
Market Insights
Community Narratives

